VGM & ASSOCIATESHealthcare MSO
Full Menu Search

Upcoming Educational Opportunities About Oxygen Policy Changes

Published in Government Relations on June 06, 2022

Have you been able to keep up with the oxygen policy updates? If the answer is no, we understand why! It’s due to all the confusion with the policy changes on top of dealing with the PHE. The latest announcement is that CMS is delaying the implementation date to January 3, 2023. Yes, that is correct. The implementation date has changed to January 2023 to be in alignment with the elimination of the CMN. Click here to read more.

Even though the initial implementation date has changed from June 2022 to January 2023 now, Ronda Buhrmester, Sr. Director of Payer Relations and Reimbursement, will move forward with offering education to the industry. Here are some opportunities to learn about the oxygen policy changes:

Click the links above to learn more and register.

In addition, on Friday, June 3, 2022, the DME MACs made a revision to the CMS-1744-IFC regarding the CMN/DIF instructions during the PHE:

CMN and DIF Instructions - Oxygen (Form CMS 484.3) and External Infusion Pumps (Form 10125)
CMS-1744-IFC stated that CMS would exercise enforcement discretion for clinical indications of coverage for the oxygen NCDs and LCDs during the PHE. Numerous fields on the Certificate of Medical Necessity (CMN) for oxygen are directly related to the clinical indications. After carefully reviewing the CMN and the related claims processing issues that would result from having missing information or having clinical information for which the form was intended, CMS has determined that requirements for a CMN for oxygen claims will not be enforced during the COVID-19 PHE. The same concerns that apply to the oxygen CMN also apply to the External Infusion Pump (EIPs) DIF; therefore, the requirements for a DIF for EIP claims will also not be enforced. Suppliers should follow the guidance in the Claim Instruction section above for oxygen and EIP claims.

There is no requirement to submit a CMN or DIF during the PHE for oxygen or EIPs. If CMNs or DIFs are not submitted, suppliers must use the CR modifier and COVID-19 narrative for any oxygen or EIP claims submitted during the COVID PHE. CMNs or DIFs are not required regardless of the diagnosis or etiology necessitating the use of the CMN-related or DIF-related DME. Use of the CR modifier and COVID-19 narrative simply reflects that the claim was submitted during the COVID PHE.

Click here to learn more.

TAGS

  1. billing & reimbursement
  2. education
  3. hme
  4. vgm
  5. vgm government

Get Connected

Stay up-to-date on the latest resources and news provided by VGM & Associates.

Sign Up for Email

From Our Experts

CRT Bill H.R. 1703 Advances Through Full Energy & Commerce Committee thumbnail CRT Bill H.R. 1703 Advances Through Full Energy & Commerce Committee Earlier this week, we shared that H.R. 1703 advanced through the House Energy & Commerce Health Subcommittee. We are pleased to report that the bill has continued to gain momentum and has now successfully passed out of the full Energy & Commerce Committee unanimously following today's markup. Important Update: Prior Auth Exemption Process – Deadline Extended to May 26, 2026 thumbnail Important Update: Prior Auth Exemption Process – Deadline Extended to May 26, 2026 CMS has just announced that the deadline to opt out of the prior authorization exemption and continue submitting prior authorization requests has been extended to Tuesday, May 26. This extension only applies to suppliers that received a letter from the DME MACs in early March regarding their prior authorization exemption status. CRT Bill H.R. 1703 Advances Through Energy and Commerce Health Subcommittee thumbnail CRT Bill H.R. 1703 Advances Through Energy and Commerce Health Subcommittee As announced during the NCART and AAHomecare Legislative Conference last week, H.R. 1703, the Choices for Increased Mobility Act, was considered and advanced out of the House Energy & Commerce Health Subcommittee. This is a positive step forward for the CRT community. VGM Government Relations Team Advocates for DME in Washington, D.C. thumbnail VGM Government Relations Team Advocates for DME in Washington, D.C. VGM Government Relations team members joined industry leaders in Washington, D.C., this week for a series of impactful advocacy events, including the 2026 AAHomecare Legislative Conference, NCART Legislative Conference, and the AAHomecare Payer Relations Council meeting. BREAKING NEWS: Big Win For DME Industry in North Carolina thumbnail BREAKING NEWS: Big Win For DME Industry in North Carolina Congratulations to ACMESA on the passage of a Medicaid funding bill, which provides important stability for DMEPOS providers and the patients they serve. Invite Your Federal Legislator to the CRT Product Expo in Washington, D.C. thumbnail Invite Your Federal Legislator to the CRT Product Expo in Washington, D.C. During the upcoming NCART/iNRRTS U.S. Rehab Legislative Conference, NCART and U.S. Rehab will host a Complex Rehab Technology (CRT) Product Expo on May 13 from 11:30 a.m. to 2:00 p.m. in Washington, D.C. This Expo is a valuable opportunity for members of Congress and their staff to see firsthand how CRT products impact independence, mobility, and quality of life for individuals with disabilities. Network Bidding Opens New Path for Small DMEPOS Suppliers thumbnail Network Bidding Opens New Path for Small DMEPOS Suppliers CMS released a new FAQ clarifying that small DMEPOS suppliers may form networks to collectively meet licensure, accreditation, and enrollment requirements for the next round of the Competitive Bidding Program. This guidance creates a new pathway for small suppliers to compete, with additional education and networking support available through VGM initiatives. VGM Group Highlights Value of DMEPOS Industry and Commends Efforts to Protect Patients and Communities thumbnail VGM Group Highlights Value of DMEPOS Industry and Commends Efforts to Protect Patients and Communities VGM Group continues to underscore the effectiveness and efficiency of the Durable Medical Equipment, Prosthetics, Orthotics, and Supplies (DMEPOS) industry and its critical role across the healthcare continuum. The services and support provided by DMEPOS suppliers not only enhance patient outcomes and strengthen community health, but do so in a cost-effective manner that delivers meaningful savings to the healthcare system.

Together We Will Make Sure You Get Paid

LEARN MORE ABOUT HOW WE CAN HELP